Fulcrum Therapeutics (FULC) Prepaid Assets (2018 - 2026)
Fulcrum Therapeutics (FULC) reported Prepaid Assets of $5.4 million for Q1 2026, up 7.62% year-over-year from $5.0 million in Q1 2025, and up 3.46% quarter-over-quarter from $5.2 million in Q4 2025.
Fulcrum Therapeutics (FULC) Prepaid Assets (2018 - 2026) Analysis & Trends
Fulcrum Therapeutics (FULC) has 9 years of Prepaid Assets data on file, last reported at $5.4 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $5.4 million, up 7.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.4 million (up 7.62% YoY), and the FY2025 annual result was $5.2 million, down 23.98% from the prior year.
- Prepaid Assets improved to $5.4 million in Q1 2026 per FULC's latest filing, from $5.2 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $6.8 million in Q4 2024 and troughed at $47000.0 in Q1 2022.
- A 5-year average of $4.5 million and a median of $4.9 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets soared 37845.45% in 2022, then slumped 98.35% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $4.4 million in 2022, then rose by 24.54% to $5.4 million in 2023, then grew by 25.09% to $6.8 million in 2024, then dropped by 23.98% to $5.2 million in 2025, then increased by 3.46% to $5.4 million in 2026.
- Business Quant data shows FULC's Prepaid Assets at $5.4 million in Q1 2026, $5.2 million in Q4 2025, and $5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Fulcrum Therapeutics | 267.90 Mn | 267.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.35 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Sep 30, 2025 | 5.22 Mn |
| Jun 30, 2025 | 69,000.00 |
| Mar 31, 2025 | 4.97 Mn |
| Dec 31, 2024 | 6.81 Mn |
| Sep 30, 2024 | 6.60 Mn |
| Jun 30, 2024 | 4.18 Mn |
| Mar 31, 2024 | 4.64 Mn |
| Dec 31, 2023 | 5.44 Mn |
| Sep 30, 2023 | 4.82 Mn |
| Jun 30, 2023 | 4.13 Mn |
| Mar 31, 2023 | 4.89 Mn |
| Dec 31, 2022 | 4.37 Mn |
| Sep 30, 2022 | 5.14 Mn |
| Jun 30, 2022 | 4.17 Mn |
| Mar 31, 2022 | 47,000.00 |
| Sep 30, 2021 | 4.67 Mn |
| Jun 30, 2021 | 11,000.00 |
| Mar 31, 2021 | 258,000.00 |